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INTRODUCTION

Stable isotopes such as deuterium ([2H]), carbon ([13C]), nitrogen ([15N]), and oxygen ([18O]
) are widely employed in contemporary science. Generating an isotopologue by incorporating a single isotope can propel a compound to ''front line'' applications in medicinal chemistry, 1 toxicology, 2 biology, 3 structural biology, 4 and mechanism determination. 5 Differences in physical properties are evident in comparisons of otherwise identical, natural-isotope-abundant compounds with isotope-enriched isotopologues. Thus, the seemingly trivial substitution of a hydrogen atom for a deuterium atom (2-fold greater mass) affords a compound with a shorter, stronger C-[2H] bond and modifies its polarity, molar volume, Van der Waal properties, dipole moment, pKa, and lipophilicity; all of these can, but not always will, afford detectable chemical-reactivity and/or physicochemical differences. Isotope-dependent technologies require not only state-of-the-art instrumentation but also, importantly, convenient and efficient synthetic routes to compounds with unambiguous, site-specific isotope incorporation. Taking these points into consideration, isotope chemistry goes beyond academic interest or research curiosity; it is instead at the forefront of a raft of technologies that exploit labeled compounds in a plethora of cutting-edge applications. For example, over 3,400 volatile organic compounds (VOCs) have been
The Bigger Picture
Single-and multiple-labeled stable-isotope-derived compounds have a myriad of cutting-edge applications that span 21 st century science, e.g., the development of new pharmaceuticals, the determination of protein structure, and the production of novel materials-the list goes on. Readily accessible methods that afford compounds labeled with single or multiple and identical or different isotopes are very important. Remarkably, despite global interest in organoBrønsted acid catalysis and isotope chemistry, these have yet to be ''dovetailed.'' We report a ''one size fits all'' asymmetric synthesis protocol that allows one, two, three, etc., readily available isotope-derived starting materials to be incorporated into an important class of heterocycles that are easily transformed into a-amino acids. Isoorganocatalysis affords straightforward access to labeled compounds whose long-term ubiquitous use in solving problems in academic, biological, medicinal, pharmaceutical, agrochemical, materials, and pharmaceutical sectors is, now, an easier proposition.
detected in deep alveolar breath. 6 This biological medium is a treasure trove of information relating to dysfunctional metabolic processes. Uniting isotope chemistry and synthetic chemistry, non-invasive ''breathomics'' allows a personalized-medicine approach to identifying patients who would benefit from a particular targeted therapy. 7 Only by dovetailing the site-specific synthesis of [13C]H 3 -1 with an understanding of tumor metabolism and IR spectrometry is it possible to use 1 as a non-invasive precision-medicine tool. Indeed, the direct relationship among advances in state-of-the-art equipment, development of contemporary analytical techniques, and software has allowed huge gains in the detection sensitivity of isotopes. The result? An upsurge of technologies and associated synthesis methodology exploiting single-or multiisotope-derived compounds.
The growing demand for molecules that incorporate single or multiple different isotopes can be further highlighted by their key use in biophysical analytical techniques. These include 1 H-NMR for in situ metabolic analysis 8 using [13] C 2 -dopamine, in vivo screening of inhibitors using long-lifetime hyperpolarizable [13] C- [2] H-bioprobes, 9 NMR-based stereo-array [13] C- [2] H-isotope labeling for determining protein structure, 10 rate-constant analysis in enzyme-catalyzed reactions, 11 stimulated Raman scattering for imaging proteome degradation, 12 metabolic fingerprinting, 13 in vivo labeling of proteins in living cells, 14 coherent anti-Stokes Raman spectroscopy for determining the bacteriorhodpsin photocycle, 15 [13] C= [18] O-labeled peptides and 2D IR spectroscopy for amylin-inhibitor complexation, 16 stimulated emission depletion microscopy with [13] C- [15] N-a-amino acids in correlated optical and isotopic nanoscopy, 17 multi-isotope imaging mass spectrometry 18 for protein study, proteomicsand mass-spectrometry-based MARQUIS and iTRAQ using labeled peptides, 19 triple-resonance isotope-edited NMR using [13] C- [15] N-pyrimidines for monitoring catabolism and drug activity, 20 deuterated starting materials in physical organic chemistry as kinetic isotope probes of reaction mechanisms, 21 and stable-isotope-labeled pharmaceuticals as internal standards for pharmaceutical bioanalysis. 22 Installing an isotope at a specific location within a desirable and tractable compound is an expensive, often deceptively difficult undertaking in comparison to generating its naturally abundant counterpart; the difficulty increases substantially when multiple and different isotopes are required at specific sites via a single asymmetric reaction. Catalysis underpins modern synthetic chemistry 23, 24 and is built on three pillars:
(1) transition-metal catalysis, 25 (2) biocatalysis, 26, 27 which also includes microalgae, and (3) organocatalysis; these three examples have been used exclusively to generate optically active isotope-labeled compounds. In stark contrast, the development and application of organo-Brønsted-acid-mediated protocols that transform isotope-derived starting materials into high-value products is non-existent. The third pillar must be strengthened! Exploiting ''better, milder, faster, cheaper'' organocatalysis has matured to such an extent that it is now, more often than not, the first port of call in planning a synthetic route to a high-value product with a specific form and function. [28] [29] [30] [31] [32] Surprisingly,
given all the aforementioned examples of isotope applications, two aspects of important contemporary science, that is, organo-Brønsted acid catalysis and isotope chemistry, have yet to be dovetailed together.
From an organocatalysis point of view, developing an isotope-incorporating protocol that generates compounds with one isotope or, especially, multiple and different isotopes presents specific problems that necessitate special consideration. From a reaction-screening and product-optimization perspective, both enantiomeric forms of the desired organocatalyst should be commercially available and in sufficient quantity or synthesized from cheap, readily available starting materials.
To ensure widespread utilization, the starting materials should have >90% isotope enrichment. It is, however, worth noting that there are far fewer commercialisotope-enhanced starting materials than natural-isotope-abundant starting materials. These need to be readily generated from the corresponding naturalisotope-abundant precursors with the use of commercial, easy-to-handle sources of isotope-derived reagents, e.g. A particular concern with isotope-derived compounds or methodology incorporating isotopes is ''scrambling.'' Yet to be developed is an organo-Brønsted acid protocol that has excellent substrate scope and allows, at will, isotope ''switching''-that is, the incorporation and transformation of starting materials with multiple different or identical isotope ''patterns'' into isotope-defined products without scrambling and with excellent levels of incorporation. The importance of being able to ''dial up and lock in''-that is, insert an isotope into a predetermined position on a molecule and ensure that it remains in position-stems from the extremely difficult task of separating scrambled compounds. Therefore, it is critical, at the outset, that a reaction be sufficiently robust that it transforms structurally and functionally diverse derived starting materials consistently and reliably into products with >95 atom % site-specific ''dialed up and locked in'' isotopes.
Syntheses of isotope-labeled aziridines have focused mainly on incorporating [2H]
and, to a significantly lesser extent, [13C] . In summary, they utilize one or more of the following: multi-step protocols; strongly basic reaction conditions; and/or formation of hazardous nitrene intermediates that require toxic metal salts that afford, in some cases, [2H]-aziridines in low yields and/or with reduced levels of [2H] incorporation.
33-49
As outlined in Figure 2 , we report an organocatalysis milestone: a one-pot, multicomponent, asymmetric organo-Brønsted-acid-catalyzed aza-Darzens reaction that ''dials up and locks in'' one or more identical or different isotopes into optically active aziridines.
Our protocol uses an easy-to-synthesize catalyst that transforms cheap, readily synthesized starting materials into high-value aziridines with excellent levels of isotope incorporation, yield, and diastereo-and stereoselectivities. Confirming their status and utility, aziridines are readily transformed into a plethora of functionalized and optically active ''secondary'' products with ring opening, affording a straightforward entry point to isotope-derived natural or unnatural a-amino acids, e.g., 3 ( Figure 2 ). Further substantiating their importance as secondary products is their transformation into sought-after tertiary products, e.g., alkaloids, antibiotics, heteroaromatic rings, and heterocyclic peptides with, again, chemoselectively ''dialed in'' isotopes. 50 Because non-isotope-enhanced aziridines and a-amino acids are important, it is not surprising that this extends to their isotopologue counterparts. 72 We report an organocatalytic approach to isotope incorporation that supplements and is complementary to transition-metal and biocatalysis approaches. A conceptually straightforward ''mix and match'' approach, outlined in Figure 3 , includes a convenient entry point to optically active aziridines adorned with different types and numbers of identical or different isotopes and, importantly, generates them by using a handful of readily synthesized simple core starting materials. Developing an isotope-enhanced protocol should, in many respects, mirror the advantages associated with conventional, non-isotope-enhanced organocatalytic reactions. They should be straightforward to set up, require minimal maintenance, and have no requirements for specialist equipment, e.g., gloveboxes, (photo)bioreactors, fermenters, or pressurized facilities for handling gases. Preferably, there should be no requirement for highly inert, rigorously anhydrous atmospheres or ultra-dry solvents.
Our procedure employs low-cost, ''out of the box'' screw-capped vials or crimpsealed microwave tubes, and importantly, the levels of laboratory expertise required for executing single-and multi-isotope organo-Brønsted-acid-catalyzed reactions are comparable. Indeed, the process of generating one, two, three, or four, etc., isotope-derived optically active aziridines is identical. In a comparison of organic and transition-metal catalysts, the differences are clear: many of the latter require ligand and metal pre-complexation before the starting materials are added (often, the metal salts and/or ligands are expensive and sensitive to air and/or moisture, which complicates handling). In contrast, shelf-stable organo-Brønsted acids are weighed with no special precautions to preclude air or water; the catalyst is added with the reactants and removed by a simple filtration through alumina or silica gel. Additionally, many structurally and functionally diverse asymmetric organo-Brønsted acids are commercially available in both optical forms or can be easily generated in gram quantities.
RESULTS AND DISCUSSION
Independently, both organo-Brønsted acid catalysis and multicomponent reactions 73 have an impressive and established track record of synthetic transformations.
Not surprisingly, when these are dovetailed, the resulting protocols are robust and powerful methods for the construction of molecular species 74, 75 augmented with complexity, but importantly, they are generated via fewer synthetic operations, isolations, and purification steps. [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] Organo-Brønsted acids, e.g., BINOL-phosphoric acid based on 4, are privileged catalysts. Symptomatic of their use is N-substituted imine protonation and activation, a widely employed strategy for lowering the lowest unoccupied molecular orbital energies of C=N bonds while increasing their susceptibility to nucleophilic attack. With this tactic, racemic or optically active non-isotope-enhanced aziridines can be generated from alkyl diazoacetates and in situ synthesized or preformed N-substituted imines. [92] [93] [94] [95] [96] [97] Given the widespread and operational simplicity of organo-Brønsted acid ''imine activation,'' it is somewhat surprising that an isotope-incorporating variant of the aza-Darzens reaction has not been reported.
Initiating our research, we screened organocatalysts 4-8 for their ability to ''activate'' imine 9 by allowing its reaction with a-[2H]-diazoester 10 or 11 98 (E)-1-phenyl-N-(pyridyl-2-ylmethylene)methanamine 9, we surmised that protontransfer from 4-8 would generate an intramolecular bifurcated hydrogen bond [99] [100] [101] [102] between the two sp 2 nitrogens and afford an optically active and electrophilic immonium ion pair (13) . Our rationale for this approach, and its potential benefits, originated from published density functional theory (DFT) calculations (BHandHLYP method) on an asymmetric Mannich reaction that indicated that a bifurcated hydrogen bond was able to activate and create a rigid optically active environment around an N-(2-hydroxyphenyl)-derived imine. 103 Disappointingly, 4-8 were unable to activate 9, and no reaction was observed. Indeed, 9 was returned with good mass balance even when (1) the reaction was performed neat, i.e., [2H]-10 was the solvent; (2) the reaction occurred in the presence of 4 Å molecular sieves to remove any potentially detrimental trace amounts of water; (3) 4-8 were left for 120 hr at ambient temperature and subsequently at an elevated temperature, rescinding the possibility of a slow reaction; (4) 4-8 were increased to 20 mol %, negating the possibility that they had poor catalyst turnovers; and (5) a series of solvents with diverse dielectric properties were investigated in a search for a strong ''solvent effect.'' All to no avail.
Failure to generate a sufficiently activated form of 9 could have been associated with the relatively low pKa of 4-8, i.e., $13 in MeCN. On the contrary, (R)-and (S)-BINOL N-triflylphosphoramides (14) are, as outlined in Figure 4 , considerably more reactive and acidic (pKa of $6.5 in MeCN). 104 As a consequence, these have widespread We next undertook a substrate study incorporating an array of preformed structurally and functionally diverse N-(2-tert-butoxyphenyl)imines based on 18 (Table 1) , sterically demanding [2H]-11, and catalyst (S)-17. Employing preformed imines rather than generating them in situ assured us that any lack of reaction or low yield was not associated with slow or incomplete N-(2-tert-butoxyphenyl)imine formation at À80 C. We confirmed the utility of (S)-17 to mediate the efficient synthesis of [2H] C 2 -labeled aziridines by incorporating a diverse array of unfunctionalized monocyclic aromatic (e.g., benzaldehyde), multicyclic aromatic (e.g., 2-naphthaldehyde), and substituted aromatic (e.g., 4-chloro, 4-bromo, 4-fluoro, pentafluoro, 4-nitro, 4-cyano, 4-(O-Fmoc)phenyl) carboxaldehydes, as well as heterocyclic 2-pyridinecarboxaldehyde. All were successfully synthesized in good (55%) to excellent (97%) yields and, in the majority of examples, excellent ee (90%-99%); see, for example, 16 and 22-29 in Table 1 Preliminary results indicate that (S)-17 is an excellent activator of preformed N-(2-tert-butoxyphenyl)imines, given that it induced very good levels of diastereo-and stereoselectivity within a diverse array of N-(2-tert-butoxyphenyl)- 121 Reacting these with 2-tert-butoxyaniline 34, tert-butyl a-diazoacetate 35, and (R)-17 (10 mol %) in our standard onepot, multi-component, two-step protocol afforded [2H]C 3 -aziridines 37-43; chiral column HPLC analysis confirmed that they had been generated with high to excellent ee. Furthermore, Consistent with previous chemistry outlined in Table 3 ). Currently, it is unclear why the 2-chlorophenyl-and 3-chlorophenylafford lower ee than the halide-derived examples above or pentafluoro-[2H]C 2 -26 (97% ee); it does, however, seem specifically related to the inclusion of a 2-or 3-chlorophenyl and is not solely a consequence of the electronegativity of chlorine.
123
Having established a preference for catalyst 17 to afford cis-aziridines, we sought a tentative mechanistic rational to help explain their formation. Protonation, (S)-17, of the N-arylimine nitrogen attached to the bulky ortho-tert-butoxyaryl substituent (54) diazoacetate proceed via intermediates with increased steric congestion (58, a clash between tert-butyl ester and bulky N-aryl group) or require 120 rotation around the newly formed central C-C bond of 59 so that the -N 2 leaving group is in a suitable orientation for S N 2 displacement and ring closure (57) via nucleophilic attack of the aryl nitrogen atom (Scheme 1). The preference for generating cis-aziridines instead of trans-aziridines is interesting and worthy of comment. 124 Similar to cis-21, Newman projections 60-62 (Scheme 1) present a clearer understanding of why this is the case. Generating trans-21 requires that the diazo leaving group be antiperiplanar to the incoming nucleophilic aryl nitrogen; however, as outlined in 62, this conformation results in a severe clash between the bulky tert-butyl ester and the N-bound ortho-tert-butoxyaryl group. This results in a transition state with increased energy, and consequently trans-21 is not generated. In contrast, although 60 and 61 (Scheme 1) have reduced steric interactions, both conformations have the diazo leaving group in the wrong conformation (not anti-periplanar to the incoming arylamine nucleophile). Indeed, the only way that 60 and 61 can afford trans-21 is via a 120 clockwise (60) or anti-clockwise (61) rotation around the central C-C bond.
However, doing this only serves to re-establish the severe steric interactions observed in 62; consequently, 60 and 61 are unlikely to be efficient pathways to trans-21. A comprehensive mechanistic and computational study that fully explains the stereoselectivity observed with triflimide (S)-17 or (R)-17 has yet to be undertaken. However, using high-level quantitative ONIOM (Our Own N-layered Integrated Molecular Orbital and Molecular Mechanics) calculations, Goodman et al. developed a BINOL-derived phosphoric acid (based on 4; Figure 4 ) model that helps explain the observed stereoselectivities when nucleophiles add to imines. 125 Extrapolating the Goodman bifunctional phosphoric acid imine activation model by substituting a triflimide group for the hydroxyl group of the phosphoric acid affords a quadrant model that projects the catalyst with the BINOL oxygens in the plane of the paper (blue bonds and atoms, 63; Scheme 2), the triflimide above (pink atoms and bonds), and the P=O group below (red bonds and atoms), each with the bulky 3-and 3 0 -aryl groups on either side. E-imines (e.g., 54; Scheme 1) are more stable than Z-imines; consequently, aldimines have a larger energy difference between the Eand Z-forms. Although a type I Z-transition state (data not shown) is more compact, the energy required to rotate the ortho-tert-butoxyphenyl is greater than the energy of the steric interactions with the large 3,3 0 -substituents. With this in mind, we propose that, similarly to 63, 54 generates an activated type I E-hydrogen-bonded transition-state complex (Scheme 2) with the bulky ortho-tert-butoxyaryl group projecting into the left-hand empty quadrant. Binding the tert-butyl a-[2H]diazoacetate to the P=O within the second vacant quadrant aligns the nucleophile directly below the activated imine double bond of 63, affording a complex similar to 64. Stereoselective attack of the a-[2H]diazoacetate generates a new optically active C-C bond with the diazo leaving group anti-periplanar to the arylamine group; subsequent cyclisation affords the desired optically enhanced aziridine cis-21.
By exploiting the quadrant model (66, Figure 6 ) and incorporating new catalysts, it could be possible to increase the stereoselectivity and/or rate of the aza-Darzens reaction. As noted, activating the imine of 9 with phosphoric acid 4 (pKa = 3.15 in DMSO) was not possible. Replacing it, however, with the more acidic (S)-17 (pKa = À3.36 in DMSO) activated the imine and afforded the cis-aziridines. Thus, testing second-generation, more acidic catalysts such as 67 (pKa À3.83 in DMSO) and 68 (pKa À4.58 in DMSO; Figure 6 ) will allow the important aspect of pKa to be probed. Similarly, incorporating TRIP-derived N-triflimide 69 and sulfur-and selenium-substituted N-triflimides 70 and 71 (anticipated to have similar a pKa to 67 and 68) will allow investigation of the effect that larger 3-and 3 0 -substituents have on the stereoselectivity and reaction rate. Furthermore, Yamamoto and Sai 126 recently reported an asymmetric Hosomi-Sakurai reaction catalyzed by 72; improved diastereo-and enantioselectivity was attributed to the incorporation of the perfluoroalkyl tether and the bulky tert-butyldiphenylsilyl groups, which increased the steric bias within the filled quadrants I and IV (66; Figure 6 ). Exploiting this, synthesizing aziridines with increased optical activities via enhanced reaction rates by using lower catalyst loadings seems viable.
Optically active a-and/or b-deuterated natural and unnatural a-amino acids are important (bio)chemical motifs (see Figures 2H-2P ) mainly generated via multi-step, enolatebased chemistry using Schö llkopf bis-lactim ethers, Evans oxazolidinones, Williams' oxazoline, Oppolzers' sultam, or Seebach imidazolidinone chiral auxiliaries.
127-141
The development of an operationally simple, catalysis-based protocol that transforms easily accessible starting materials into cis-aziridines ''en route'' to natural or unnatural, optically active, isotope-enhanced a-amino acids holds considerable merit. Isotopeenhanced a-amino acids are valuable bioprobes that have been used for investigating protein-protein interactions, 142 identifying unknown compounds from orphan gene clusters (the so-called genomisotopic approach), 143 and determining the metabolic (76) in 80% and 64% yields, respectively ( Figure 7) . Importantly, both retained their excellent levels of deuterium incorporation (>95 atom %), and chiral column HPLC analysis established that they had 77% and 97% ee, respectively ( Figures S65-S68 ).
The synthesis of unnatural b-(aminoaryl) and b-(haloaryl) a-amino acids, e.g., 77 and 78, respectively, (Figure 7) , is an important endeavor worthy of investigation. [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] Only three isotope-enhanced 4-aminophenylalanines 161, 162 have been reported.
Two of these detail the deuterium incorporation within the side chain groupsnot, as would be preferable, at one or both of the a-or b-carbons on the a-amino propanoic acid chain (see a b-Hydroxy-a-amino acids are key components of important bioactive natural products, e.g., vancomycin (antibacterial), bouvardin (anticancer), orenticin (antibacterial), phomopsins (mycotoxin), ristocetin (antibiotic), and actaplanin (antibiotic). Furthermore, they are also essential building blocks for the synthesis of b-lactams, b-fluoro-a-amino acids, and carbohydrates. Consequently, many examples of asymmetric synthesis strategies afford non-isotope-enhanced b-hydroxy-b-aryl-a-amino acids. A non-exhaustive list includes lithium amide conjugate addition, 172 transition-metal-mediated hydroborylations, 173 the use of chiral auxiliaries (i.e., oxazolidinones, 174 oxazolines, 175 and bislactim ethers 176 ), and substrate-specific biocatalysis. Biosynthesis studies using multi-isotope labelled par a-aminophenylalanine, 90 difco yeast extract glucose Furthermore, and of particular concern, recovered 97 had significantly reduced (70%) deuterium incorporation. In summary, neither of these transition-metal-based methods is particularly suited to bespoke isotope incorporation; instead, they afford presumably inseparable isotopologues of b-hydroxy-b-aryl-a-amino acids with relatively poor levels of isotope incorporation.
181,182
The potential for exploiting an organo-Brønsted-acid-promoted hydrolytic ring opening of isotope-labeled aziridines offered an alternative (cf. Scheme 3), efficient, operationally straightforward entry point to these high-value entities. Employing cheap ''off the shelf'' 4-toluenesulfonic acid (PTSA), aqueous acetonitrile (1:1), and mild reaction conditions readily transformed [2H]C 3 -37 and [2H]C 3 -38 (Table 2) (Figure 7 ), in unoptimized 86% and 75% yields, respectively ( Figures S85-S88 ). Importantly, there was no evidence of deuterium scrambling or reduced incorporation ([2H] > 95 atom %). Furthermore, chiral column HPLC analysis confirmed no erosion of their optical purities. Encouragingly, a conceptually important next step was to reinforce the utility of our methodology by generating unusual, highly functionalized, isotope-labeled, optically active a-or b-[2H]-b-iodo-a-amino esters 86 and 87 ( Figure 7) . In a slightly modified procedure, 183 [2H]C 2 -27 and [2H]C 3 -43 reacted in 20 min with iodine-and polystyrene-immobilized thiophenol. Gratifyingly, b-iodo-a-amino esters b-[2H]-86 and a-[2H]-87 were afforded with >95 atom % deuterium incorporation in unoptimized 81% and 86% yields and 79% and 84% ee, respectively ( Figures S89-S92 ). Further transformation of these benzyl-activated a-amino acids, affording highly functionalized, desirable isotope-labeled building blocks, seems feasible. To address the shortfall of aziridines appended with multiple and differentiated isotopes, we considered our isotope ''mix and match'' approach ( Figure 3) Figure 8) .
A notable isotope milestone we wanted to add to our expanding repertoire of isotopes was [13C] (cf. Figure 1 ). Figures S106-S111 ). Both were generated via identical protocols, and the products were afforded in essentially equal yields ( Figure 8) Furthermore, there was no reduction in optical purity, isotope ''washout,'' or scrambling of the deuterium and all isotopes in >95 atom % (Figures S124-S126 ).
In conclusion, we have developed an exciting approach that allows the installation of single or multiple and identical or different isotopes into a sought-after class of heterocycles. The exceptional ease of our process offers further prospects for isotope incorporation; it uses mild conditions, is operationally straightforward, and is cost effective. Utilizing readily available starting materials and an organo-Brønsted acid catalyst, it transforms, with equal ease, combinations of isotope-enhanced or naturally abundant starting materials into optically active aziridines with site-specific isotope inclusion. Demonstrating the broad utility of our process, the resulting aziridines are readily transformed into isotope-derived, secondary ''high-value feedstocks'' based on natural or unnatural a-or b-substituted optically active a-amino acids. The future requirements of isotope-derived compounds are increasing; therefore, the design and synthesis of reactions and catalysts that facilitate the incorporation of single or multiple isotopes is almost certainly going to intensify. As the first example of an isotope-incorporating organo-Brønsted acid protocol, we anticipate that our work will open the door to the development of a raft of alternative isoorganocatalytic chemistry. Ultimately, easier access to isotopelabeled compounds will assist chemists and biologists in gaining a better understanding of the fundamental processes associated with the health and well-being research-intensive sectors of the biotech, medtech, agritech, pharmaceutical, and academic communities alike.
EXPERIMENTAL PROCEDURES
Synthesis of 2-(2H)-tert-Butyl-1-(2-tert-butoxyphenyl)-3-(perfluorophenyl) aziridine-2-carboxylate: 26 Pentafluorobenzaldehyde (40 mg, 0.26 mmol), O-tert-butoxyaniline (43 mg, 0.26 mmol), and catalyst (S)-17 (22 mg, 0.027 mmol, 10%) were added to a flame-dried Biotage 2 mL microwave vial under nitrogen. 800 mL of [2H]chloroform was added (pre-dried over 4 Å molecular sieves), and the vial was sealed with a polytetrafluoroethylene crimp cap. 200 mL of anhydrous dichloromethane (DCM) was added via syringe through the septum, and the reaction mixture was cooled to À80 C. After 30 min, >95% deuterated tert-butyl a[2H]diazoacetate (40 mL, 0.29 mmol) was added via syringe, and the reaction mixture was stirred at À80 C. It was monitored by 1 H-NMR until the reaction was deemed complete.
At this point, the reaction mixture was passed through a short plug of silica and eluted with diethyl ether. The solvents were removed under reduced pressure, and the residue was purified by flash chromatography (14% diethyl ether in 40 C-60 C petroleum ether). A sample was submitted to chiral column analytical HPLC analysis (iso-hexane/iso-propanol = 95/5, 1 mL/min, 3.97 min (first peak), 5.14 min (second peak), 97% ee; Chiralpak AD). Optically active 
